← Open Payments lookup

MARK LADNER: Open Payments

NPI 1487753562 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,076 in 9 payments from 6 companies in 2025. Trend: 2023 $496 · 2024 $243 · 2025 $1,076

Food & beverage: $1,076
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.3$378
Axsome Therapeutics, Inc.2$220
Neurocrine BioSciences, Inc.1$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$130
Janssen Pharmaceuticals, Inc1$125
Teva Pharmaceuticals USA, Inc.1$89

Products named: COBENFY, Auvelity, INGREZZA, CAPLYTA, SPRAVATO, AUSTEDO XR.

Industry payments across MS — which companies pay providers there.